EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials

Mohammed A. Elbahloul, Shrouk Ramadan, Eman E. Labeeb, Shahed Aldalahmeh, Ahella Ismail A. Mousa, Ahmed Elazab, Ahmed N. Mohamed, Ahmad Elashery, Mehiar O. El-Hamdani, Carl J. Lavie, Gregg W. Stone

Circulation: Cardiovascular Interventions · 2026-07 · 19 (7)

DOI: 10.1161/circinterventions.126.016601 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND: The ideal timing for complete revascularization (CR) in patients with ST-segment–elevation myocardial infarction and multivessel disease is uncertain. This meta-analysis examined outcomes of immediate CR (ICR) versus staged CR (SCR). METHODS: Four databases were searched for randomized controlled trials that compared ICR and SCR in ST-segment–elevation myocardial infarction and multivessel disease. The primary end points of interest were short-term and long-term all-cause mortality. Outcomes are presented as risk ratios for short-term outcomes and incidence rate ratios for long-term outcomes with 95% CIs. RESULTS: The analysis included 9 randomized controlled trials in which 4213 patients were enrolled. Short-term all-cause mortality occurred in 2.0% of patients after ICR compared with 1.2% of patients after SCR (risk ratio, 1.66 [95% CI, 0.99–2.78], P =0.053; I 2 =0%). Short-term cardiac death was increased after ICR (risk ratio, 2.19 [95% CI, 1.08–4.44], P =0.03; I 2 =0%). At a median 1-year follow-up, all-cause mortality occurred in 4.7% of patients after ICR compared with 3.5% of patients after SCR (incidence rate ratio, 1.40 [95% CI, 0.97–2.03], P =0.07; I 2 =0%). No significant differences were identified between the ICR and SCR strategies at either short-term or long-term follow-up for other outcomes, including myocardial infarction, repeat revascularization, stent thrombosis, stroke, major bleeding, and the composite of major adverse cardiac or cerebrovascular events. CONCLUSIONS: In hemodynamically stable patients with ST-segment–elevation myocardial infarction and multivessel disease, an ICR strategy may increase short-term cardiac death compared with SCR, and the possibility of increased early and late all-cause mortality cannot be excluded. Despite some uncertainty, these results currently favor a staged CR strategy for most patients with ST-segment–elevation myocardial infarction and multivessel disease. REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD420251163719.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →